Pretibial myxedema (thyroid dermopathy)

Research output: Chapter in Book/Report/Conference proceedingChapter

2 Citations (Scopus)

Abstract

Editorial Perspective: Pretibial myxedema (thyroid dermopathy) is the sine qua non of the dermatologic manifestations of thyroid disease. Although any medical student can reflexively state that pretibial myxedema is a hallmark of Graves disease, how many clinicians realize that the term is a misnomer? That thyroid dermopathy is not necessarily limited to the pretibial region and is not exclusively seen in patients with Graves disease are just two facts frequently misconceived about this condition. The reality is that much has been learned about the immunologic pathogenesis of thyroid der-mopathy, a condition that results from the accumulation of the glycosaminoglycans, hyaluronic acid, and chondroitin sulfate in the dermis. A precise understanding of its pathogenesis, however, remains to be determined. This chapter surveys the clinical, biological, and therapeutic landscape of thyroid dermopathy. By understanding its natural history, eliminating or reducing predisposing factors such as smoking and obesity, appreciating the complexities of the immunologic aberrations leading to mucin deposition, and having a logical approach to therapy, clinicians should be able to at least ameliorate this chronic, occasionally severe, recalcitrant disorder.

Original languageEnglish (US)
Title of host publicationThyroid Disorders with Cutaneous Manifestations
PublisherSpringer Berlin Heidelberg
Pages103-119
Number of pages17
ISBN (Print)9781848001862
DOIs
StatePublished - Dec 1 2008

Fingerprint

Myxedema
Thyroid Gland
Graves Disease
Chondroitin Sulfates
Thyroid Diseases
Mucins
Hyaluronic Acid
Dermis
Glycosaminoglycans
Natural History
Medical Students
Causality
Obesity
Smoking
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fatourechi, V. (2008). Pretibial myxedema (thyroid dermopathy). In Thyroid Disorders with Cutaneous Manifestations (pp. 103-119). Springer Berlin Heidelberg. https://doi.org/10.1007/978-1-84800-187-9_10

Pretibial myxedema (thyroid dermopathy). / Fatourechi, Vahab.

Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg, 2008. p. 103-119.

Research output: Chapter in Book/Report/Conference proceedingChapter

Fatourechi, V 2008, Pretibial myxedema (thyroid dermopathy). in Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg, pp. 103-119. https://doi.org/10.1007/978-1-84800-187-9_10
Fatourechi V. Pretibial myxedema (thyroid dermopathy). In Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg. 2008. p. 103-119 https://doi.org/10.1007/978-1-84800-187-9_10
Fatourechi, Vahab. / Pretibial myxedema (thyroid dermopathy). Thyroid Disorders with Cutaneous Manifestations. Springer Berlin Heidelberg, 2008. pp. 103-119
@inbook{82447ed15d9b4b6e83b153e89e2c29cf,
title = "Pretibial myxedema (thyroid dermopathy)",
abstract = "Editorial Perspective: Pretibial myxedema (thyroid dermopathy) is the sine qua non of the dermatologic manifestations of thyroid disease. Although any medical student can reflexively state that pretibial myxedema is a hallmark of Graves disease, how many clinicians realize that the term is a misnomer? That thyroid dermopathy is not necessarily limited to the pretibial region and is not exclusively seen in patients with Graves disease are just two facts frequently misconceived about this condition. The reality is that much has been learned about the immunologic pathogenesis of thyroid der-mopathy, a condition that results from the accumulation of the glycosaminoglycans, hyaluronic acid, and chondroitin sulfate in the dermis. A precise understanding of its pathogenesis, however, remains to be determined. This chapter surveys the clinical, biological, and therapeutic landscape of thyroid dermopathy. By understanding its natural history, eliminating or reducing predisposing factors such as smoking and obesity, appreciating the complexities of the immunologic aberrations leading to mucin deposition, and having a logical approach to therapy, clinicians should be able to at least ameliorate this chronic, occasionally severe, recalcitrant disorder.",
author = "Vahab Fatourechi",
year = "2008",
month = "12",
day = "1",
doi = "10.1007/978-1-84800-187-9_10",
language = "English (US)",
isbn = "9781848001862",
pages = "103--119",
booktitle = "Thyroid Disorders with Cutaneous Manifestations",
publisher = "Springer Berlin Heidelberg",

}

TY - CHAP

T1 - Pretibial myxedema (thyroid dermopathy)

AU - Fatourechi, Vahab

PY - 2008/12/1

Y1 - 2008/12/1

N2 - Editorial Perspective: Pretibial myxedema (thyroid dermopathy) is the sine qua non of the dermatologic manifestations of thyroid disease. Although any medical student can reflexively state that pretibial myxedema is a hallmark of Graves disease, how many clinicians realize that the term is a misnomer? That thyroid dermopathy is not necessarily limited to the pretibial region and is not exclusively seen in patients with Graves disease are just two facts frequently misconceived about this condition. The reality is that much has been learned about the immunologic pathogenesis of thyroid der-mopathy, a condition that results from the accumulation of the glycosaminoglycans, hyaluronic acid, and chondroitin sulfate in the dermis. A precise understanding of its pathogenesis, however, remains to be determined. This chapter surveys the clinical, biological, and therapeutic landscape of thyroid dermopathy. By understanding its natural history, eliminating or reducing predisposing factors such as smoking and obesity, appreciating the complexities of the immunologic aberrations leading to mucin deposition, and having a logical approach to therapy, clinicians should be able to at least ameliorate this chronic, occasionally severe, recalcitrant disorder.

AB - Editorial Perspective: Pretibial myxedema (thyroid dermopathy) is the sine qua non of the dermatologic manifestations of thyroid disease. Although any medical student can reflexively state that pretibial myxedema is a hallmark of Graves disease, how many clinicians realize that the term is a misnomer? That thyroid dermopathy is not necessarily limited to the pretibial region and is not exclusively seen in patients with Graves disease are just two facts frequently misconceived about this condition. The reality is that much has been learned about the immunologic pathogenesis of thyroid der-mopathy, a condition that results from the accumulation of the glycosaminoglycans, hyaluronic acid, and chondroitin sulfate in the dermis. A precise understanding of its pathogenesis, however, remains to be determined. This chapter surveys the clinical, biological, and therapeutic landscape of thyroid dermopathy. By understanding its natural history, eliminating or reducing predisposing factors such as smoking and obesity, appreciating the complexities of the immunologic aberrations leading to mucin deposition, and having a logical approach to therapy, clinicians should be able to at least ameliorate this chronic, occasionally severe, recalcitrant disorder.

UR - http://www.scopus.com/inward/record.url?scp=79851491766&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79851491766&partnerID=8YFLogxK

U2 - 10.1007/978-1-84800-187-9_10

DO - 10.1007/978-1-84800-187-9_10

M3 - Chapter

AN - SCOPUS:79851491766

SN - 9781848001862

SP - 103

EP - 119

BT - Thyroid Disorders with Cutaneous Manifestations

PB - Springer Berlin Heidelberg

ER -